Gene Expression Profile Scores by Allomap ® are Higher in Heart Transplant Patients with Non-Skin Cancer Malignancy

Gene expression profile (GEP) monitoring by AlloMap ® is ISHLT-guideline recommended for graft surveillance after heart transplant (HT). The Outcomes in AlloMap Registry (OAR) is an observational, prospective study of HT patients monitored by AlloMap. The effect of malignancy on AlloMap scores is not well characterized. The large cohort of OAR patie nts with clinical data associated with AlloMap scores permits this characterization.

Source: The Journal of Heart and Lung Transplantation - March 31, 2020 Category: Transplant Surgery Authors: K. Khush, A. Kao, H. Eisen, S. Hall Tags: (704) Source Type: research